Search

Your search keyword '"Benlalam H"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Benlalam H" Remove constraint Author: "Benlalam H"
23 results on '"Benlalam H"'

Search Results

4. Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer.

5. Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells.

6. Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinoma.

7. Merkel cell carcinoma and cellular cytotoxicity: sensitivity to cellular lysis and screening for potential target antigens suitable for antibody-dependent cellular cytotoxicity.

8. Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAF V600E Melanoma Lines with Vemurafenib.

9. CD40L confers helper functions to human intra-melanoma class-I-restricted CD4 + CD8 + double positive T cells.

10. IL-9 promotes the survival and function of human melanoma-infiltrating CD4(+) CD8(+) double-positive T cells.

11. Soluble HLA-I/peptide monomers mediate antigen-specific CD8 T cell activation through passive peptide exchange with cell-bound HLA-I molecules.

12. Regulation of gap junctions in melanoma and their impact on Melan-A/MART-1-specific CD8⁺ T lymphocyte emergence.

13. Hypoxia-dependent inhibition of tumor cell susceptibility to CTL-mediated lysis involves NANOG induction in target cells.

14. Cytotoxic T cells - stroma interactions.

15. The anti-angiogenic activity of IL-12 is increased in iNOS-/- mice and involves NK cells.

16. Endothelial cells as key determinants of the tumor microenvironment: interaction with tumor cells, extracellular matrix and immune killer cells.

17. Gap junction communication between autologous endothelial and tumor cells induce cross-recognition and elimination by specific CTL.

18. ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathway.

19. Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients.

20. [Immunotherapy of cancer: promise and reality].

21. Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes.

22. A ras-mutated peptide targeted by CTL infiltrating a human melanoma lesion.

23. Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy.

Catalog

Books, media, physical & digital resources